Biocon Investor Relations Material
Latest events
Q4 24/25
Biocon
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Biocon Ltd
Access all reports
Biocon Limited operates through Biologics, Branded Formulations, and Research Services segments. The Biologics segment sells pharmaceutical products and services to regulated markets, including India and United States; the India market through alliance partners and sale of clinical trial material; various countries in Asia Pacific and Middle East and Africa through alliance partners; and the Europe market through its subsidiary Biocon Norway. Biocon Limited was founded in 1978 and is headquartered in Bengaluru, India.
Key slides for Biocon Ltd
Q3 24/25
Biocon Ltd
Q2 24/25
Biocon Ltd
Latest articles
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
)
Costco Wholesale: The Model of Scalable Simplicity
Costco's rise from warehouse club to retail giant is built on low prices, scale efficiency, and a model designed for lasting customer value.
26 May 2025
Ticker symbol
BIOCON
Country
🇮🇳 India